Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

Kan Yonemori; Noriyuki Katsumata; Hajime Uno; Koji Matsumoto; Tsutomu Kouno; Shinya Tokunaga; Yasuhiro Yamanaka; Chikako Shimizu; Masashi Ando; Masahiro Takeuchi; Yasuhiro Fujiwara

首页> 外文期刊>Breast Cancer Research and Treatment >Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

【24h】

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

机译：每周紫杉醇对多西他赛耐药的转移性乳腺癌患者的疗效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background. Partial cross-resistance to paclitaxel and docetaxel has been demonstrated in pre-clinical studies.

机译：背景。临床前研究已证明对紫杉醇和多西紫杉醇有部分交叉耐药性。

著录项

来源
《Breast Cancer Research and Treatment》 |2005年第3期|237-241|共5页
作者
Kan Yonemori; Noriyuki Katsumata; Hajime Uno; Koji Matsumoto; Tsutomu Kouno; Shinya Tokunaga; Yasuhiro Yamanaka; Chikako Shimizu; Masashi Ando; Masahiro Takeuchi; Yasuhiro Fujiwara;
展开▼
作者单位

Breast and Medical Oncology Division Department of Medical Oncology National Cancer Center Hospital;

Breast and Medical Oncology Division Department of Medical Oncology National Cancer Center Hospital;

Division of Biostatistics Kitasato University Graduate School;

Breast and Medical Oncology Division Department of Medical Oncology National Cancer Center Hospital;

Breast and Medical Oncology Division Department of Medical Oncology National Cancer Center Hospital;

Breast and Medical Oncology Division Department of Medical Oncology National Cancer Center Hospital;

Breast and Medical Oncology Division Department of Medical Oncology National Cancer Center Hospital;

Breast and Medical Oncology Division Department of Medical Oncology National Cancer Center Hospital;

Breast and Medical Oncology Division Department of Medical Oncology National Cancer Center Hospital;

Division of Biostatistics Kitasato University Graduate School;

Breast and Medical Oncology Division Department of Medical Oncology National Cancer Center Hospital;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
docetaxel; metastatic breast cancer; paclitaxel; predictive factor; resistance; taxane;

机译：多西紫杉醇;转移性乳腺癌;紫杉醇;预测因子;耐药性;紫杉烷;

相似文献

外文文献
中文文献
专利

1. Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer. [J] . Yonemori K, Katsumata N, Uno H, Breast cancer research and treatment. . 2005,第3期

机译：每周紫杉醇对多西他赛耐药的转移性乳腺癌患者的疗效。
2. Paclitaxel administered weekly in patients with docetaxel-resistant metastatic breast cancer: a single-center study. [J] . Sawaki M, Ito Y, Hashimoto D, Tumori. . 2004,第1期

机译：紫杉醇对多西他赛耐药的转移性乳腺癌患者每周给药：一项单中心研究。
3. Phase II study of weekly paclitaxel for docetaxel-resistant metastatic breast cancer in Japan. [J] . Taguchi T, Aihara T, Takatsuka Y, The breast journal . 2004,第6期

机译：在日本每周进行紫杉醇治疗多西他赛耐药转移性乳腺癌的II期研究。
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Cost-Benefit Analysis of Nanoparticle Albumin-Bound Paclitaxel versus Solvent-Based Paclitaxel for the Treatment of Metastatic Breast Cancer in the United States [D] . Vichansavakul, Kittaya 2013

机译：纳米白蛋白结合紫杉醇与溶剂型紫杉醇在美国治疗转移性乳腺癌的成本效益分析
6. Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2eu Amplification as a Predictive Factor for Efficacy [O] . Hye-Suk Han, Jin-Soo Kim, Jin Hyun Park, 2009

机译：每周紫杉醇和曲妥珠单抗作为过度表达HER2的转移性乳腺癌患者的一线治疗：HER2 / neu放大的幅度作为疗效的预测因素
7. Efficacy and Safety of Weekly Paclitaxel With or Without Oral Alisertib in Patients With Metastatic Breast Cancer [O] . Joyce O’Shaughnessy, Kristi McIntyre, Sharon Wilks, 2021

机译：在转移性乳腺癌患者中，每周紫杉醇的疗效和安全性与或不含口服alisertib
8. 99-Technetium Sestamibi Scanning to Predict the Efficacy of Estramustine Phosphate in Overcoming Paclitaxel Resistance in Patients with Advanced Breast Cancer [R] . Volm, M. D. 2004

机译：99-Technetium sestamibi扫描预测雌莫司汀磷酸盐克服晚期乳腺癌患者紫杉醇耐药的疗效

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

摘要

著录项

相似文献

相关主题

期刊订阅